FABP1
MOLECULAR TARGETfatty acid binding protein 1, liver
FABP1 (fatty acid binding protein 1, liver) is targeted by 9 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting FABP1
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | Fenofibrate | 3.09 | 21 |
| 2 | Clofibrate | 2.08 | 7 |
| 3 | Oleic Acid | 1.61 | 4 |
| 4 | cbd | 0.69 | 1 |
| 5 | Prednisolone | 0.69 | 1 |
| 6 | Progesterone | 0.69 | 1 |
| 7 | cannabidiol | 0.69 | 1 |
| 8 | Gemfibrozil | 0.69 | 1 |
| 9 | Rimonabant | 0.69 | 1 |
About FABP1 as a Drug Target
FABP1 (fatty acid binding protein 1, liver) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 9 compounds with documented FABP1 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
FABP1 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.